Cours TrovaGene Inc Nasdaq
Actions
US8972383090
Recherche biotechnologique et médicale
CA 2024 * | 242 k 223 k | CA 2025 * | 66,67 k 61,33 k | Capitalisation | 195 M 179 M |
---|---|---|---|---|---|
Résultat net 2024 * | -46 M -42,32 M | Résultat net 2025 * | -57 M -52,44 M | VE / CA 2024 * | 804 x |
Trésorerie nette 2024 * | - 0 | Trésorerie nette 2025 * | - 0 | VE / CA 2025 * | 2 924 x |
PER 2024 * |
-4,47
x | PER 2025 * |
-4,14
x | Employés | - |
Rendement 2024 * |
-
| Rendement 2025 * |
-
| Flottant | 92,32% |
Dernier transcript sur TrovaGene Inc
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Mark Erlander
CEO | Chief Executive Officer | 64 | 04/03/13 |
James Levine
DFI | Director of Finance/CFO | 53 | 12/07/21 |
Tod Smeal
CTO | Chief Tech/Sci/R&D Officer | 59 | 11/01/22 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
James Armitage
BRD | Director/Board Member | 77 | 22/04/20 |
Gary Pace
BRD | Director/Board Member | 76 | 22/04/20 |
Mark Erlander
CEO | Chief Executive Officer | 64 | 04/03/13 |
Varia. 1 janv. | Capi. | |
---|---|---|
+0,17% | 42,86 Md | |
+10,92% | 42,74 Md | |
+44,30% | 41,36 Md | |
-6,20% | 27,68 Md | |
+5,23% | 25,15 Md | |
-24,79% | 18,63 Md | |
+26,69% | 12,37 Md | |
-3,13% | 11,92 Md | |
+6,57% | 11,21 Md |